3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
149
Lymphoma, Large B-Cell, Diffuse
114
Lymphoma, Non-Hodgkin
110
Precursor Cell Lymphoblastic Leukemia-Lymphoma
106
Leukemia
81
Hodgkin Disease
81
Small Cell Lung Carcinoma
79
Leukemia, Myeloid, Acute
73
Burkitt Lymphoma
69
Lymphoma, Follicular
67
Lymphoma, Mantle-Cell
65
Lung Neoplasms
60
Lymphoma, Large-Cell, Immunoblastic
54
Leukemia, Lymphocytic, Chronic, B-Cell
47
Recurrence
40
Multiple Myeloma
39
Lymphoma, B-Cell, Marginal Zone
36
Neuroblastoma
33
Congenital Abnormalities
29
Carcinoma, Non-Small-Cell Lung
28
Lymphoma, B-Cell
25
Myelodysplastic Syndromes
24
Lymphoma, Large-Cell, Anaplastic
23
Lymphoma, Extranodal NK-T-Cell
23
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
22
Brain Neoplasms
22
Sarcoma
21
Ovarian Neoplasms
21
Lymphoma, T-Cell, Peripheral
20
Central Nervous System Neoplasms
20
Interventions
Cyclophosphamide
8
fludarabine phosphate
6
fludarabine
5
Bendamustine Hydrochloride
4
Busulfan
3
AP 1903 reagent
3
pembrolizumab
2
Tacrolimus
2
Mycophenolic Acid
2
thymoglobulin
1
pimonidazole
1
palbociclib
1
ibritumomab tiuxetan
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Rivaroxaban
1
Rituximab
1
Radiotherapy
1
Plasmalyte A
1
Pharmacogenomic Testing
1
Melphalan
1
Hydroxychloroquine
1
Etoposide
1
Dimethyl Sulfoxide
1
Cytarabine
1
Carmustine
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Immune System Diseases
×
Etoposide
×
Clear all
NCT02366663
2018-03-12
SPINOZA
City of Hope Medical Center
Phase 3
Terminated
3 enrolled
8 charts